ORBUS THERAPEUTICS
They at Orbus are committed to bringing innovative products to the extremely underserved patients affected by rare diseases. They are focused and passionate about bringing a more positive outcome to patients facing life-threatening or significantly life-altering diseases. Currently, Orbus Therapeutics is working to develop and commercialize eflornithine in North America. The company was founded in 2012 and is headquartered in Palo Alto, California.
ORBUS THERAPEUTICS
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2012-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.orbustherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
650-656-9440
Total Funding:
55 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager Content Delivery Network Global Site Tag Typekit Squarespace Squarespace Add To Cart Stocksy
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
BiPlastiq
BiPlastiq is a startup dedicated to developing radical technological advancements.
Carbylan Therapeutics
Carbylan Therapeutics was founded in 2004
i-Optics
i-Optics offers eye diagnosis solutions and products for age related eye diseases.
Odyssey Therapeutics
Odyssey Therapeutics provides medicines to patients with inflammatory diseases and cancer.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
PolyCore Therapeutics
PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Stemline Therapeutics
Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.
Current Advisors List
Current Employees Featured
Founder
Investors List
Agent Capital
Agent Capital investment in Series B - Orbus Therapeutics
Adams Street Partners
Adams Street Partners investment in Series A - Orbus Therapeutics
Ernest Mario
Ernest Mario investment in Series A - Orbus Therapeutics
H.I.G. BioHealth Partners
H.I.G. BioHealth Partners investment in Series A - Orbus Therapeutics
Longitude Capital
Longitude Capital investment in Series A - Orbus Therapeutics
Official Site Inspections
http://www.orbustherapeutics.com
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
